-
Mashup Score: 15February 2025 decisions news release - 2 month(s) ago
10 February 2025 The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday, February 10) published advice on seven medicines. Cabotegravir (Apretude ®) was accepted to help prevent sexually transmitted HIV-1 infections in adults and adolescents who are at high risk of being infected. Cemiplimab (Libtayo ®) was accepted for the treatment of adults with recurrent or metastatic cervical cancer, where the cancer has progressed on or after
Source: scottishmedicines.org.ukCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 27
ICR welcomes NICE recommendation of olaparib for advanced breast cancer
Source: www.icr.ac.ukCategories: General Medicine News, Oncologists1Tweet-
We're pleased that @NICEComms have recommended that olaparib can be used for NHS patients with advanced #BreastCancer. The treatment offers the chance of longer, healthier lives for people with breast cancer caused by faulty #BRCA1 or #BRCA2 genes. https://t.co/o9f73JXrvq https://t.co/OOgwrXDonT
-
-
Mashup Score: 14February 2025 decisions news release - 2 month(s) ago
10 February 2025 The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday, February 10) published advice on seven medicines. Cabotegravir (Apretude ®) was accepted to help prevent sexually transmitted HIV-1 infections in adults and adolescents who are at high risk of being infected. Cemiplimab (Libtayo ®) was accepted for the treatment of adults with recurrent or metastatic cervical cancer, where the cancer has progressed on or after
Source: scottishmedicines.org.ukCategories: General Medicine News, Oncologists1Tweet-
We’re delighted that The Scottish Medicines Consortium (SMC) has recommended olaparib for use in advanced #BreastCancer. The treatment offers the chance of longer, healthier lives for people with breast cancer caused by faulty #BRCA1 or #BRCA2 genes. https://t.co/tTwzPpl2pJ
-
-
Mashup Score: 4New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment - 3 month(s) ago
New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment
Source: www.icr.ac.ukCategories: General Medicine News, Oncologists1Tweet-
A 🆕 tool, EMBER, could improve the diagnosis and treatment of the most common type of #BreastCancer EMBER integrates two types of datasets previously seen as incompatible to provide more comprehensive information about a person’s cancer. Read more ⤵️ https://t.co/JM6NU2621C https://t.co/7aVATP04sv
-
-
Mashup Score: 10Scientists show that the immune system indirectly influences the genes that drive cancer - 3 month(s) ago
Scientists show that the immune system indirectly influences the genes that drive cancer
Source: www.icr.ac.ukCategories: General Medicine News, Oncologists1Tweet-
🤔 Could the immune system have a role in promoting common mutations in known cancer-causing genes? After assessing samples from almost 10,000 primary tumours, a team of experts believes so! This may open a new avenue of immune evasion research. https://t.co/OFbs3AQ00T https://t.co/Msym1oAQCB
-
-
Mashup Score: 3“If not for the hundreds of millions raised and invested in cancer research, I might not be here today” – Jennifer’s story - 3 month(s) ago
“If not for the hundreds of millions raised and invested in cancer research, I might not be here today” – Jennifer’s story
Source: www.icr.ac.ukCategories: General Medicine News, Oncologists1Tweet-
“I have directly benefitted from work done by the ICR” Jennifer Hollington, (@jenholl ), 58, lives in Canada and was diagnosed with #OvarianCancer in 2020. Following successful treatment, her future looks bright ♥️ Read her moving story here ⬇️ https://t.co/NfAs0UfEea https://t.co/z0Q4wDUchJ
-
-
Mashup Score: 14Prostate cancer spit test could save the NHS £500 million a year - 3 month(s) ago
Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, thanks to a new spit test which can be taken at home.
Source: www.icr.ac.ukCategories: General Medicine News, Oncologists1Tweet-
With the news that #ProstateCancer is now the most common cancer in England, there's been a lot of discussion about improving early diagnosis. At the ICR, we're researching new ways to identify men earlier who are at the highest risk of the disease ⤵️ https://t.co/TahFy13lDs https://t.co/OgAuJ7HRBh
-
-
Mashup Score: 1Supporting scientists to choose the best chemical probes - 3 month(s) ago
Supporting scientists to choose the best chemical probes
Source: www.icr.ac.ukCategories: General Medicine News, Oncologists1Tweet-
Read more about the Chemical Probes Portal here ⤵️ https://t.co/rnrXM6gJB1
-
-
Mashup Score: 2The tumour histopathology “glossary” for AI developers - 3 month(s) ago
The applications of artificial intelligence (AI) and deep learning (DL) are leading to significant advances in cancer research, particularly in analysing histopathology images for prognostic and treatment-predictive insights. However, effective translation of these computational methods requires computational researchers to have at least a basic understanding of histopathology. In this work, we aim to bridge that gap by introducing essential histopathology concepts to support AI developers in their research. We cover the defining features of key cell types, including epithelial, stromal, and immune cells. The concepts of malignancy, precursor lesions, and the tumour microenvironment (TME) are discussed and illustrated. To enhance understanding, we also introduce foundational histopathology techniques, such as conventional staining with hematoxylin and eosin (HE), antibody staining by immunohistochemistry, and including the new multiplexed antibody staining methods. By providing this es
Source: journals.plos.orgCategories: General Medicine News, Oncologists1Tweet-
Are you using #AI to analyse #Histopathology images? A team of ICR researchers have created a glossary to help AI developers understand tumour histopathology. They hope that this will speed up the development of AI algorithms for cancer research ⤵️ https://t.co/quSs0CFGxV
-
-
Mashup Score: 5Uncovering the secrets of the secretome – underexplored cells near tumours may hold the answer to drug resistance - 3 month(s) ago
Uncovering the secrets of the secretome – underexplored cells near tumours may hold the answer to drug resistance
Source: www.icr.ac.ukCategories: General Medicine News, Oncologists1Tweet-
Can non-cancerous cells near tumours affect cancer’s response to treatment? 🤔 Based on our recent research, factoring in the effects of some of these cells may improve drug development and help determine the optimal use of existing medications. Read ⤵️ https://t.co/0lgukZ0b01 https://t.co/QXGaPyW0Xu
-
We’re delighted that The Scottish Medicines Consortium (SMC) has recommended olaparib for use in advanced #BreastCancer. The treatment offers the chance of longer, healthier lives for people with breast cancer caused by faulty #BRCA1 or #BRCA2 genes. https://t.co/tTwzPpl2pJ